πŸ‡ΊπŸ‡Έ FDA
Patent

US 9238676

Peptide and peptidomimetic inhibitors

granted A61KA61K38/00A61K38/10

Quick answer

US patent 9238676 (Peptide and peptidomimetic inhibitors) held by RA PHARMACEUTICALS, INC. expires Mon Jan 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
RA PHARMACEUTICALS, INC.
Grant date
Tue Jan 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K38/00, A61K38/10, A61K45/06, A61K47/60